ATE228007T1 - Verwendung von wachstumshormone - Google Patents
Verwendung von wachstumshormoneInfo
- Publication number
- ATE228007T1 ATE228007T1 AT97919856T AT97919856T ATE228007T1 AT E228007 T1 ATE228007 T1 AT E228007T1 AT 97919856 T AT97919856 T AT 97919856T AT 97919856 T AT97919856 T AT 97919856T AT E228007 T1 ATE228007 T1 AT E228007T1
- Authority
- AT
- Austria
- Prior art keywords
- growth hormone
- medicament
- treatment
- individuals
- metabolic
- Prior art date
Links
- 102000018997 Growth Hormone Human genes 0.000 title abstract 2
- 108010051696 Growth Hormone Proteins 0.000 title abstract 2
- 239000000122 growth hormone Substances 0.000 title abstract 2
- 208000004611 Abdominal Obesity Diseases 0.000 abstract 2
- 206010022489 Insulin Resistance Diseases 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 abstract 2
- 206010065941 Central obesity Diseases 0.000 abstract 1
- 102000002265 Human Growth Hormone Human genes 0.000 abstract 1
- 108010000521 Human Growth Hormone Proteins 0.000 abstract 1
- 239000000854 Human Growth Hormone Substances 0.000 abstract 1
- 206010020772 Hypertension Diseases 0.000 abstract 1
- 102000004895 Lipoproteins Human genes 0.000 abstract 1
- 108090001030 Lipoproteins Proteins 0.000 abstract 1
- 208000001145 Metabolic Syndrome Diseases 0.000 abstract 1
- 230000003187 abdominal effect Effects 0.000 abstract 1
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 abstract 1
- 230000004075 alteration Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000002503 metabolic effect Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Emergency Medicine (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Child & Adolescent Psychology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Fodder In General (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9601397A SE9601397D0 (sv) | 1996-04-12 | 1996-04-12 | Use of growth hormone |
PCT/SE1997/000601 WO1997038709A1 (en) | 1996-04-12 | 1997-04-10 | Use of growth hormone |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE228007T1 true ATE228007T1 (de) | 2002-12-15 |
Family
ID=20402176
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT97919856T ATE228007T1 (de) | 1996-04-12 | 1997-04-10 | Verwendung von wachstumshormone |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP0935469B1 (de) |
JP (1) | JP2000510451A (de) |
AT (1) | ATE228007T1 (de) |
CA (1) | CA2250907A1 (de) |
DE (1) | DE69717301T2 (de) |
DK (1) | DK0935469T3 (de) |
ES (1) | ES2187771T3 (de) |
NZ (1) | NZ332105A (de) |
PT (1) | PT935469E (de) |
SE (1) | SE9601397D0 (de) |
WO (1) | WO1997038709A1 (de) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6087090A (en) * | 1997-02-25 | 2000-07-11 | Celtrix Pharmaceuticals, Inc. | Methods for predicting drug response |
PT1007085E (pt) * | 1997-07-04 | 2002-05-31 | Pharmacia Ab | Utilizacao da hormona de crescimento em composicoes para o tratamento da resistencia a insulina no coracao |
CA2352316A1 (en) | 1998-11-26 | 2000-06-02 | Auckland Uniservices Limited | Treatment of hypertension |
TW514510B (en) * | 1999-06-11 | 2002-12-21 | Tanita Seisakusho Kk | Method and apparatus for measuring distribution of body fat |
JP2003534237A (ja) * | 1999-11-03 | 2003-11-18 | ノボ ノルディスク アクティーゼルスカブ | 食欲の抑制又は満腹の惹起のための成長ホルモン又は成長ホルモン分泌促進物質の使用 |
SE0000837D0 (sv) * | 2000-03-13 | 2000-03-13 | Pharmacia & Upjohn Ab | New use |
AU2006200127B2 (en) * | 2000-03-13 | 2007-10-25 | Pfizer Inc. | Use of growth hormone in low dose |
ES2333097T3 (es) | 2000-05-31 | 2010-02-17 | Raqualia Pharma Inc | Uso de secretagogos de la hormona de crecimiento para estimular la motilidad gastrointestinal. |
EP1411924A1 (de) * | 2001-07-06 | 2004-04-28 | Auckland Uniservices Limited | Behandlung der hypertonie |
US7476653B2 (en) | 2003-06-18 | 2009-01-13 | Tranzyme Pharma, Inc. | Macrocyclic modulators of the ghrelin receptor |
US7833964B2 (en) | 2003-08-21 | 2010-11-16 | Tercica, Inc. | Methods of reducing visceral fat by increasing levels of insulin-like growth factor-I (IGF-I) |
US8440695B2 (en) * | 2005-11-09 | 2013-05-14 | St Jude Children's Research Hospital | Use of chloroquine to treat metabolic syndrome |
CU23558A1 (es) | 2006-02-28 | 2010-07-20 | Ct Ingenieria Genetica Biotech | Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento |
EP2644618B1 (de) | 2007-02-09 | 2016-08-17 | Ocera Therapeutics, Inc. | Intermediaten für die Synthese von Makrozyklische Ghrelin-Rezeptormodulatoren |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5268277A (en) * | 1987-08-07 | 1993-12-07 | Eniricerche S.P.A. | Method for the preparation of human growth hormone |
-
1996
- 1996-04-12 SE SE9601397A patent/SE9601397D0/xx unknown
-
1997
- 1997-04-10 NZ NZ332105A patent/NZ332105A/xx unknown
- 1997-04-10 AT AT97919856T patent/ATE228007T1/de not_active IP Right Cessation
- 1997-04-10 JP JP09537020A patent/JP2000510451A/ja active Pending
- 1997-04-10 DK DK97919856T patent/DK0935469T3/da active
- 1997-04-10 EP EP97919856A patent/EP0935469B1/de not_active Expired - Lifetime
- 1997-04-10 WO PCT/SE1997/000601 patent/WO1997038709A1/en active IP Right Grant
- 1997-04-10 CA CA002250907A patent/CA2250907A1/en not_active Abandoned
- 1997-04-10 ES ES97919856T patent/ES2187771T3/es not_active Expired - Lifetime
- 1997-04-10 PT PT97919856T patent/PT935469E/pt unknown
- 1997-04-10 DE DE69717301T patent/DE69717301T2/de not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JP2000510451A (ja) | 2000-08-15 |
DE69717301T2 (de) | 2003-09-04 |
DK0935469T3 (da) | 2003-03-17 |
CA2250907A1 (en) | 1997-10-23 |
EP0935469B1 (de) | 2002-11-20 |
DE69717301D1 (de) | 2003-01-02 |
WO1997038709A1 (en) | 1997-10-23 |
EP0935469A1 (de) | 1999-08-18 |
NZ332105A (en) | 2000-03-27 |
PT935469E (pt) | 2003-03-31 |
ES2187771T3 (es) | 2003-06-16 |
SE9601397D0 (sv) | 1996-04-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE228007T1 (de) | Verwendung von wachstumshormone | |
DE69809558D1 (de) | Auswahlmethode für potentielle mittel gegen fettleibigkeit, zur regulierung des ucp-2 | |
Blair et al. | Sustained compression and healing of chronic venous ulcers. | |
Thivel et al. | Surgical weight loss: impact on energy expenditure | |
EP0766966A3 (de) | Methode zur Behandlung der Insulinresistenz | |
EA200000747A1 (ru) | СПОСОБ ВВЕДЕНИЯ AspB28-ИНСУЛИНА ЧЕЛОВЕКА | |
SE9201573D0 (sv) | Use of igf-1 | |
TNSN00206A1 (en) | Method for treating diabetes | |
CA2196174A1 (en) | Use of ketoconazole and related substances in medicaments for treatment of type ii diabetes | |
DE69534084D1 (de) | Verwendung von prolactinmodulatoren und diät zur herstellung eines medikamentes zur behandlung der fettleibigkeit | |
WO2002070546A3 (en) | Modified derivatives of cck-8 | |
Foster et al. | Application of OpSite film: a new and effective treatment of painful diabetic neuropathy | |
ES2181923T3 (es) | 4-hidroxicumarin-3-carboxamidas para el tratamiento de la diabet es mellitus no dependiente de la insulina. | |
ES2166406T3 (es) | Uso de derivados de 1,5-benzodiazepina para el control del vaciado gastrico en pacientes con diabetes mellitus no dependiente de insulina. | |
DE69728654D1 (de) | Verwendung von il-7 zur behandlung von autoimmunkrankheiten, insbesondere insulinabhängigem diabetes mellitus | |
ATE333274T1 (de) | Verwendung von l-acetylcarnitin in kombination mit biotin zur behandlung von patienten mit insulinresistentem diabetes mellitus typ ii | |
ES2168772T3 (es) | Uso de hormona del crecimiento en composiciones para el tratamiento de la resistencia del corazon a la insulina. | |
Holst et al. | Diurnal profile of pancreatic polypeptide and gut glucagon in human morbid obesity | |
Tibrewal et al. | Is day surgery for Wilson's osteotomy safe? | |
SU1375255A1 (ru) | Супинатор Н.А.Шамина | |
TH23897A (th) | โปรตีนต้านความอ้วน | |
TH23897B (th) | โปรตีนต้านความอ้วน | |
RU96115219A (ru) | Способ лечения больных сахарным диабетом | |
Marris | TAHYCARDIA: OBSERVATIONS UPON ITS OCCURRENCE IN THE ENTERIC AND OTHER FEVERS | |
Delfanian et al. | Application of Living Skin Equivalent for the Treatment of Chronic Lovver-Extremity Ulcers |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 0935469 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |